Figure 3.
Cytokine and chemokines in iMCD-TAFRO. Array 1 shows plasma levels for CRP (A), serum amyloid A (SAA) (B), ferritin (D), IFN-γ (E), VEGF (F), IL-6 (G), TNF-α (H), MCP-4 (I), IL-8 (J), IL-10 (K), IP-10 (L), IL-4 (M), IL-12 (N), IL-16 (O), thymus- and activation-regulated chemokine (TARC) (P), macrophage inflammatory protein 1β (MIP-1β) (Q), and eotaxin (R). (C) sIL2Rα (CD25) was determined by ELISA. Array 1 and ELISA results are for controls (Controls), flare (Flare), 4 days after treatment (Treatment Day 4), and during remission (Remission) 6 months later.

Cytokine and chemokines in iMCD-TAFRO. Array 1 shows plasma levels for CRP (A), serum amyloid A (SAA) (B), ferritin (D), IFN-γ (E), VEGF (F), IL-6 (G), TNF-α (H), MCP-4 (I), IL-8 (J), IL-10 (K), IP-10 (L), IL-4 (M), IL-12 (N), IL-16 (O), thymus- and activation-regulated chemokine (TARC) (P), macrophage inflammatory protein 1β (MIP-1β) (Q), and eotaxin (R). (C) sIL2Rα (CD25) was determined by ELISA. Array 1 and ELISA results are for controls (Controls), flare (Flare), 4 days after treatment (Treatment Day 4), and during remission (Remission) 6 months later.

Close Modal

or Create an Account

Close Modal
Close Modal